MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing Read more about MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing
IDH1 and IDH2: founding or progressor mutations in myeloid neoplasms Read more about IDH1 and IDH2: founding or progressor mutations in myeloid neoplasms
Role of epigenetic regulators in Single Base Substitution patterns in AML Read more about Role of epigenetic regulators in Single Base Substitution patterns in AML
Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay Read more about Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay
TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity Read more about TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity
Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma Read more about Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma